Updated Coverage – PreveCeutical Medical (PRVCF, PREV)

PreveCeutical Medical (PRVCF, PREV) is an early stage life sciences company with a focus on curative and therapeutic compounds based on natural substances.   Recent announcements point to value creation by PreveCeutical in recent months.  The research and development team has made significant progress with several projects.  The updates appear to confirm the Company has been […]

Read More

Updated Coverage – Westwater Resources (WWR)

Coverage of Westwater Resources, Inc. (WWR) has been updated following report of financial performance in the quarter ending September 2018.   Recent events in each of Westwater’s target markets demonstrate the large and growing market opportunities that have been a central part of our investment thesis in Westwater, continue to develop unabated.  Perhaps more importantly the […]

Read More

Updated Coverage – PreveCeutical Medical, Inc. (PRVCF, PREV)

Early stage biotechnology company PreveCeutical Medical (PRVCF:  OTC, PREV:  CN) has made considerable progress with an ambitious research pipeline focused on preventative and curative medicines.  The Company has claimed several achievements in recent months, moving projects “closer to goal.’ We have had high hopes for the Company in 2018, and so far we have not […]

Read More

Updated Coverage – PreveCeutical Medical (PRVCF, PREV)

PreveCeutical Medical is an early stage biotech with ample risk in a nascent development pipeline.  Nonetheless, the Company has made progress with its development projects, demonstrating the ability of the scientific team to execute on the R&D agenda. Highest priority on the Company’s agenda is a non-opioid pain treatment compound based on cannabinoids and administered […]

Read More